Park Square Places Ingo Chakravarty as Operating Partner at Northpond Ventures

Park Square has placed Ingo Chakravarty as Operating Partner at Northpond Ventures. Northpond Ventures builds and supports breakthrough science and technology driven businesses to create a marked impact on humanity.

Chakravarty most recently served as Vice President and General Manager at Thermo Fisher. He held this role from 2021-2023. He was formerly the President and Chief Executive Officer at Mesa Biotech, a private developer of DNA and RNA molecular testing services, from 2020-2021. Mesa Biotech was acquired by Thermo Fisher Scientific in 2021 for $450 million. From 2016-2019, he served as President and Chief Executive Officer at NAVICAN, a private provider of a comprehensive end-to-end solution to help oncologists and patients. Prior, he was Senior Vice President and General Manager, International from 2013-2016 at GenMark Diagnostics, a public molecular diagnostics company developing sensor detection technology. GenMark Diagnostics was acquired by Roche in 2021 for $1.8 billion. From 2011-2012, Chakravarty was Vice President and General Manager, Women’s Health at Gen-Probe, a private developer of nucleic acid probe-based products for clinical diagnosis. Previously, he served as Head, Sales, Europe at Roche Tissue Diagnostics from 2009-2011. Chakravarty held a variety of leadership roles at Ventana Medical Systems from 2004-2008 and joined the company as Sales Manager in Germany and France from 1996-2003. He began his career as Sales Manager at Microm Laborgeraete from 1990-1996 in Germany.

Chakravarty received his B.S. in Electrical Engineering from Friedrich Hecker School.